-
Mashup Score: 21Crafting a Clinical Trials Hub - 25 day(s) ago
Clinical trials have the power to improve patient outcomes and save lives. Cedars-Sinai is at the forefront of innovation and expansion.
Source: www.cedars-sinai.orgCategories: General Medicine News, Hem/OncsTweet
-
Mashup Score: 29Updates in immunotherapy for skin cancer - 1 month(s) ago
In this podcast, we highlight some of the latest updates in the use of immunotherapy to treat skin cancer. This…
Source: www.vjoncology.comCategories: General Medicine News, Hem/OncsTweet
-
Mashup Score: 20Personalized Cancer Vaccines Directed against Tumor Mutations: Building Evidence from Mice to Humans - 1 month(s) ago
Abstract. Personalized vaccines directed to tumor mutations have recently gained significant momentum. On the basis of the concept of stimulating T-cell responses against neoantigens encoded by a tumor’s host of personal mutations, these vaccines utilize genome or exome sequencing, mutation calling, and epitope prediction followed by manufacturing of a customized vaccine for each patient. In their 2012 Cancer Research publication, Castle and colleagues provided evidence that vaccinating with long peptide vaccines encompassing neoantigens can generate robust immune responses and induce antitumor activity in a mouse B16F10 melanoma. This approach, harnessing the exquisite specificity of mutations to the tumor and thus providing an effective target for cancer vaccines, was subsequently shown to be safe and immunogenic in a series of small first in man trials in patients with melanoma. The field has accelerated and expanded substantially over the last 5 years, propelled by increasing evide
Source: aacrjournals.orgCategories: General Medicine News, Hem/OncsTweet
-
Mashup Score: 132024 Melanoma Updates - Justin T. Moyers, MD - MOASC 2024 - 2 month(s) ago
Justin T. Moyers, MD – Medical Oncology – The Angeles Clinic and Research Institute provides an overview of recent updates in melanoma treatment, including long-term follow-up results from the CHECKMATE-067 trial, adjuvant and neoadjuvant therapy studies, developments in adoptive cell therapy, and experimental treatments, presented at the MOASC 2024 Oncology Summit.
Source: videos.oncologytube.comCategories: General Medicine News, Hem/OncsTweet
-
Mashup Score: 20Melanoma Bridge – Immunotherapy Bridge - 4 month(s) ago
It is our pleasure to announce we are now organizing Melanoma and Immunotherapy Bridge 2023, on behalf of Fondazione Melanoma Onlus. Upcoming annual appointments for worldwide cancer clinicians and researchers, gaining more and more attendees every year, the 9th edition of Immunotherapy Bridge and the 14th edition of Melanoma Bridge will take place in Naples, Italy, from November 29 th to 30 th and from November 30 th to December 2 nd, respectively. The 2023 edition of both events will be very thrilling!
Source: www.melanomabridge.orgCategories: General Medicine News, Hem/OncsTweet
-
Mashup Score: 63Safety profile of pembrolizumab monotherapy based on an aggregate safety evaluation of 8937 patients - 4 month(s) ago
Pembrolizumab has a manageable safety profile as described in its label, which was primarily based on 2799 patients who participated in clinical trial…
Source: www.sciencedirect.comCategories: General Medicine News, Hem/OncsTweet
-
Mashup Score: 18
February 10, 2024
Source: www.gotoper.comCategories: General Medicine News, Hem/OncsTweet-
Mark your calendars,virtual 20th Annual International Symposium on Melanoma Feb. 10! World-renowned experts discuss recent evolving care in melanoma and more! Use code: HAMID for free registration. Register now: https://t.co/5VauFmbJAh #gotoPER #IME24 @OmidHamidMD @DrSapnaPatel https://t.co/1NSXrDS5RA
-
-
Mashup Score: 11Cancer Care Centers West Los Angeles and Santa Monica | The Angeles Clinic and Research Institute - 4 month(s) ago
The Angeles Clinic & Research Institute has established an international reputation for developing new cancer therapies.
Source: www.theangelesclinic.orgCategories: General Medicine News, Hem/OncsTweet
-
Mashup Score: 9
February 10, 2024
Source: www.gotoper.comCategories: General Medicine News, Hem/OncsTweet-
#medtwitter Join me at 20th Annual International Symposium on Melanoma and Other Cutaneous Malignancies® February 10, 2024 There's much to learn and discuss. GET FREE REGISTRATION WHEN YOU USE MY LAST NAME (HAMID) AS A DISCOUNT CODE https://t.co/RAGHpSekXx @DrSapnaPatel… https://t.co/nTr8fGzJk0 https://t.co/Ma5LowWc4b
-
-
Mashup Score: 9
February 10, 2024
Source: www.gotoper.comCategories: General Medicine News, Hem/OncsTweet-
#medtwitter Join me at 20th Annual International Symposium on Melanoma and Other Cutaneous Malignancies® February 10, 2024 There's much to learn and discuss. GET FREE REGISTRATION WHEN YOU USE MY LAST NAME (HAMID) AS A DISCOUNT CODE https://t.co/RAGHpSekXx @DrSapnaPatel… https://t.co/nTr8fGzJk0 https://t.co/Ma5LowWc4b
-
Bravo @drmikefarkouh working to make @CedarsSinaiMed @angelesclinic a one stop shop for #clinicaltrials We are here for it and ready to enlist ! https://t.co/2VfP7Rxm1U https://t.co/cnnGNlI32P